Abstract
Aging is accompanied by not only a decrease in visual function but also an increase in the incidence of ocular disease. The lens becomes yellow and increases in translucency, and the pupil becomes smaller. The decrease in vision with age, however, is due to more than just a decrease in the intensity of the light reaching the retina. Quantitative decreases in the various visual functions have been demonstrated, including dark adaptation and visual fields.
“Age melts with unperceived decay.”
Samuel Johnson
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Drance S, Berry V, Hughes A. Studies on the effects of age on the central and peripheral isopters of the visual field in normal subjects. Am J Ophthalmol. 1967; 63: 1667–1672.
Sekuler R, Hutman L. Spatial vision and aging. I: Contrast sensitivity./Gerontol. 1980; 35: 692–699.
Millodot M. The influence of age on the sensitivity of the cornea. Invest Ophthalmol Visual Sci. 1977; 16: 240–242.
Duane A. An attempt to determine the normal range of accommodation at various ages—being a revision of Donders’ experiments. Trans Am Ophthalmol Soc. 1908; 11: 634–639.
Vision Problems in the US. Schaumburg, IL: Prevent Blindness America; 1994.
Kuwabara T. The maturation of the lens cell: a morphologic study. Exp Eye Res. 1975; 20: 427–433.
Goldmann H. Senile changes of the lens and the vitreous. Am J Ophthalmol. 1964; 57: 1–13.
Tripathi R, Tripathi B. Lens morphology, aging, and cataract./Gerontol. 1983; 38: 258–270.
Perkins E. Lens thickness in early cataract. Br J Ophthalmol. 1988; 72: 348–353.
Duke-Elder W. The pathological action of light upon the eye. Lancet. 1926; 1: 1188–1191.
Harding J, Crabbe J. The lens: development, protein, metabolism and cataract. In: Davson H, ed. Vegetative Physiology and Biochemistry: The Eye. 3rd eji, vol. 16. London: Academic Press; 1984: 207.
Guyton D. Preoperative visual acuity evaluation. Int Ophthalmol Clin. 1987; 27: 140–148.
Duke-Elder W. Diseases of the inner eye. In: Textbook of Ophthalmology. Vol. 3. St. Louis: C. V. Mosby; 1945: 3183.
O’Malley P, et al. Paving-stone degeneration of the retina. Arch Ophthalmol. 1965; 73: 169–182.
Ferris F. Senile macular degeneration: review of epidemiologic features. Am J Epidemiol. 1983; 118: 132–151.
Pizzarello L. The dimensions of the problem of eye disease among the elderly. Ophthalmology. 1987; 94: 1191–1195.
Kornzweig A, Feldstein M, Schneider J. The eye in old age. IV. Ocular survey of over one thousand aged persons with special reference to normal and disturbed visual function. Am J Ophthalmol. 1957; 44: 29–37.
Viggosson G, Bjornsson G, Ingvason J. The prevalence of open-angle glaucoma in Iceland. Acta Ophthalmol. 1986; 64: 138–141.
Fontana S, Brubaker R. Volume and depth of the anterior chamber in the normal aging human eye. Arch Ophthalmol. 1980; 98: 1803–1808.
Hollows F, Graham P. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Brit J Ophthalmol. 1966; 50: 570–586.
Kahn H. The prevalence of chronic simple glaucoma in the United States. Am J Ophthalmol. 1972; 74: 355–359.
Bannister R. A treatise of one hundred and thirteen diseases of the eyes and eye-liddes. Felix Kyngston for Thomas Man, Paternoster-row, at the sign of the Talbot: 1922.
Graefe von A. Beitrage zur pathologie und therapie des glaucoms. Arch Ophthalmol. 1869; 15: 108–252.
Barkan O. Glaucoma: classification, causes, and surgical control. Results of microgonioscopic research. Am J Ophthalmol. 1938; 21: 1099–1117.
Colton T, Ederer F. The distribution of intraocular pressures in the general population. Surv Ophthalmol. 1980; 25: 123–129.
Becker B. The decline in aqueous secretion and outflow facility with age. Am J Ophthalmol. 1958; 46: 731–736.
Armaly M. On the distribution of applanation pressure. I. Statistical features and the effect of age, sex, and family history of glaucoma. Arch Ophthalmol. 1965; 73: 11–18.
Kass M, Sears M. Hormonal regulation of intraocular pressure. Surv Ophthalmol. 1977; 22: 153–176.
Airaksinen P, Drance S, Schulzer M. Neuroretinal rim area in early glaucoma. Am J Ophthalmol. 1985; 99: 1–4.
Quigley H, et al. Blood vessels of the glaucomatous optic disc in experimental primate and human eyes. Invest Ophthalmol Vis Sci. 1984; 25: 918–931.
Drance S, Begg I. Sector haemorrhage—a probable acute ischemic disc change in chronic simple glaucoma. Can J Ophthalmol. 1970; 5: 137–141.
Quigley H, Miller N, George T. Clinical evaluation of nerve fiber layer atrophy as an indicator of glaucomatous optic nerve damage. Arch Ophthalmol. 1980; 98: 1564–1571.
Tyler C. Specific deficits of flicker sensitivity in glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 1981; 20: 204–212.
Quigley H, Addicks E, Green W. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982; 100: 135–146.
Hart W, Becker B. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982; 89: 268–279.
Zimmerman T. Topical ophthalmic beta blockers: a comparative reviews. J Ocular Pharm. 1993; 9 (4): 373–384.
Wise J, Witter S. Argon laser therapy for open-angle glaucoma. A pilot study. Arch Ophthalmol. 1979; 97: 319–322.
Forbes M, Bansal R. Argon laser goniophotocoagulation of the trabecular meshwork in open-angle glaucoma. Trans Am Ophthalmol Soc. 1981; 79: 257–275.
Levene R. Glaucoma filtering surgery: factors that determine pressure control. Ophthalmic Surg. 1984; 15: 475–183.
Kahn H, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974; 78: 58–67.
Klein R, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984; 102: 520–526.
Klein R, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984; 102: 527–532.
Ernest J, Goldstick T, Engerman R. Hyperglycemia impairs retinal oxygen autoregulation in normal and diabetic dogs. Invest Ophthalmol Vis Sci. 1983; 24: 985–989.
Aiello L, et al. Diabetic retinopathy in Joslin clinic patients with adult-onset diabetes. Ophthalmology. 1981; 88: 619–623.
Klein R, et al. The Wisconsin epidemiologic study of diabetic retinopathy. Ophthalmology. 1984; 91: 1464–1474.
Engerman R, Bloodworth Jr J, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes. 1977; 26: 760–769.
Cogan D, Toussaint D, Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol. 1961; 66: 366–378.
Cunha-Vaz J, et al. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes. Am J Ophthalmol. 1978; 86: 467^73.
Changes and Diseases of the Aging Eye
Ashton N. Injection of the retinal vascular system in the enucleated eye in diabetic retinopathy. Br J Ophthalmol. 1950; 34: 38–41.
Grunwald J, et al. Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol. 1986; 104: 991–996.
Muraoka K, Shimizu K. Intraretinal neovascularization in diabetic retinopathy. Ophthalmology. 1984; 91: 1440–1446.
Dobree J. Proliferative diabetic retinopathy. Evolution of the retinal lesions. Br J Ophthalmol. 1964; 48: 637–649.
Davis M. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol. 1965; 74: 741–751.
Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol. 1985; 103: 1796–1806.
Stevens T, Castrovinci R, de Venecia G. Aphakia-exacerbated exudative diabetic retinopathy. The Association for Research in Vision and Ophthalmology Spring Meeting, Sarasota, Florida, April 26–30, 1976; 6: 98.
Gutman F. Evaluation of a patient with central retinal vein occlusion. Ophthalmology. 1983; 90: 481–83.
Green W, et al. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina. 1981; 1: 27–55.
Hayreh S, et al. Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983; 90: 488–506.
Archer D, Ernest J, Newell F. Branch retinal vein obstruction. A classification. Trans Am Acad Ophthalmol Otolaryngol. 1974; 78: 148–165.
Orth D, Pätz A. Retinal branch vein occlusion. Surv Ophthalmol. 1978; 22: 357–376.
Appen R, Wray S, Cogan D. Central retinal artery occlusion. Am J Ophthalmol. 1975; 79: 374–381.
Brown G, Shields J. Cilioretinal arteries and retinal arterial occlusion. Arch Ophthalmol. 1979; 97: 84–92.
Hayreh S. Anterior Ischemic Optic Neuropathy. New York: Springer-Verlag; 1975.
Bibliography
Kwitko ML, Weinstock FJ, eds. Geriatric Ophthalmology. Orlando, FL: Grune & Stratton; 1985.
Rosenbloom AA Jr, Morgan, MW. Vision and Aging, General and Clinical Perspectives. New York: Fairchild; 1986.
Weale, RA. The Aging Eye. New York: Harper & Row; 1963.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ernest, J.T. (1997). Changes and Diseases of the Aging Eye. In: Cassel, C.K., et al. Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-2705-0_45
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2705-0_45
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-2707-4
Online ISBN: 978-1-4757-2705-0
eBook Packages: Springer Book Archive